Page last updated: 2024-10-30

leflunomide and Lassitude

leflunomide has been researched along with Lassitude in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Woerkom, JM1
Kruize, AA1
Geenen, R1
van Roon, EN1
Goldschmeding, R1
Verstappen, SM1
van Roon, JA1
Bijlsma, JW1

Trials

1 trial available for leflunomide and Lassitude

ArticleYear
Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.
    Annals of the rheumatic diseases, 2007, Volume: 66, Issue:8

    Topics: Adult; Aniline Compounds; Crotonates; Diarrhea; Facial Dermatoses; Fatigue; Female; Humans; Hydroxyb

2007